PortfoliosLab logoPortfoliosLab logo
CHGCY vs. WEBNF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CHGCY vs. WEBNF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chugai Pharmaceutical Co Ltd ADR (CHGCY) and Westpac Banking Corp (WEBNF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CHGCY achieves a -9.40% return, which is significantly lower than WEBNF's 0.20% return. Over the past 10 years, CHGCY has outperformed WEBNF with an annualized return of 15.87%, while WEBNF has yielded a comparatively lower 14.12% annualized return.


CHGCY

1D
-0.63%
1M
-9.64%
YTD
-9.40%
6M
-8.99%
1Y
-10.93%
3Y*
20.51%
5Y*
5.43%
10Y*
15.87%

WEBNF

1D
-0.21%
1M
-4.68%
YTD
0.20%
6M
7.01%
1Y
24.75%
3Y*
29.50%
5Y*
11.82%
10Y*
14.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CHGCY vs. WEBNF - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CHGCY
Chugai Pharmaceutical Co Ltd ADR
-9.40%21.53%17.55%48.78%-21.63%-38.50%72.01%59.87%13.53%72.59%
WEBNF
Westpac Banking Corp
0.20%39.75%34.48%5.37%10.13%52.61%-8.36%6.69%-16.10%23.08%

Correlation

The correlation between CHGCY and WEBNF is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Nov 24, 2010

0.08

Fundamentals

Market Cap

CHGCY:

$78.34B

WEBNF:

$62.48B

EPS

CHGCY:

$144.42

WEBNF:

$5.69

PE Ratio

CHGCY:

0.16

WEBNF:

4.43

PEG Ratio

CHGCY:

0.01

WEBNF:

0.54

PS Ratio

CHGCY:

0.06

WEBNF:

0.80

PB Ratio

CHGCY:

0.04

WEBNF:

0.88

Total Revenue (TTM)

CHGCY:

$1.36T

WEBNF:

$77.68B

Gross Profit (TTM)

CHGCY:

$970.13B

WEBNF:

$43.56B

EBITDA (TTM)

CHGCY:

$699.55B

WEBNF:

$10.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Chugai Pharmaceutical Co Ltd ADR

Westpac Banking Corp

Often compared with CHGCY:
CHGCY vs. GSK

Return for Risk

CHGCY vs. WEBNF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CHGCY
CHGCY Risk / Return Rank: 3030
Overall Rank
CHGCY Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
CHGCY Sortino Ratio Rank: 2929
Sortino Ratio Rank
CHGCY Omega Ratio Rank: 2929
Omega Ratio Rank
CHGCY Calmar Ratio Rank: 3333
Calmar Ratio Rank
CHGCY Martin Ratio Rank: 3131
Martin Ratio Rank

WEBNF
WEBNF Risk / Return Rank: 6060
Overall Rank
WEBNF Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
WEBNF Sortino Ratio Rank: 5555
Sortino Ratio Rank
WEBNF Omega Ratio Rank: 5757
Omega Ratio Rank
WEBNF Calmar Ratio Rank: 6464
Calmar Ratio Rank
WEBNF Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CHGCY vs. WEBNF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Chugai Pharmaceutical Co Ltd ADR (CHGCY) and Westpac Banking Corp (WEBNF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CHGCYWEBNFDifference

Sharpe ratio

Return per unit of total volatility

-0.25

0.51

-0.75

Sortino ratio

Return per unit of downside risk

-0.04

1.06

-1.09

Omega ratio

Gain probability vs. loss probability

0.99

1.15

-0.16

Calmar ratio

Return relative to maximum drawdown

-0.24

1.20

-1.44

Martin ratio

Return relative to average drawdown

-0.52

3.36

-3.87

CHGCY vs. WEBNF - Sharpe Ratio Comparison

The current CHGCY Sharpe Ratio is -0.25, which is lower than the WEBNF Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of CHGCY and WEBNF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CHGCYWEBNFDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.25

0.51

-0.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.16

0.29

-0.13

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

0.36

+0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

0.18

+0.33

Drawdowns

CHGCY vs. WEBNF - Drawdown Comparison

The maximum CHGCY drawdown since its inception was -59.68%, smaller than the maximum WEBNF drawdown of -66.96%. Use the drawdown chart below to compare losses from any high point for CHGCY and WEBNF.


Loading charts...

Drawdown Indicators


CHGCYWEBNFDifference

Max Drawdown

Largest peak-to-trough decline

-59.68%

-66.96%

+7.28%

Max Drawdown (1Y)

Largest decline over 1 year

-30.79%

-20.54%

-10.25%

Max Drawdown (3Y)

Largest decline over 3 years

-33.18%

-23.44%

-9.74%

Max Drawdown (5Y)

Largest decline over 5 years

-45.45%

-31.14%

-14.31%

Max Drawdown (10Y)

Largest decline over 10 years

-59.68%

-61.21%

+1.53%

Current Drawdown

Current decline from peak

-29.19%

-17.57%

-11.62%

Average Drawdown

Average peak-to-trough decline

-16.07%

-21.03%

+4.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.06%

7.37%

+6.69%

Volatility

CHGCY vs. WEBNF - Volatility Comparison

The current volatility for Chugai Pharmaceutical Co Ltd ADR (CHGCY) is 10.86%, while Westpac Banking Corp (WEBNF) has a volatility of 11.84%. This indicates that CHGCY experiences smaller price fluctuations and is considered to be less risky than WEBNF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CHGCYWEBNFDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.86%

11.84%

-0.98%

Volatility (6M)

Calculated over the trailing 6-month period

31.78%

32.54%

-0.76%

Volatility (1Y)

Calculated over the trailing 1-year period

44.89%

48.91%

-4.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.58%

41.25%

-6.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.01%

39.33%

-6.32%

Dividends

CHGCY vs. WEBNF - Dividend Comparison

CHGCY's dividend yield for the trailing twelve months is around 1.79%, while WEBNF has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CHGCY
Chugai Pharmaceutical Co Ltd ADR
1.79%1.62%0.86%0.00%1.19%0.00%0.00%0.00%0.00%0.00%1.64%1.41%
WEBNF
Westpac Banking Corp
0.00%2.78%8.39%8.91%7.82%42.62%3.83%14.51%19.31%16.01%0.00%0.00%

Financials

CHGCY vs. WEBNF - Financials Comparison

This section allows you to compare key financial metrics between Chugai Pharmaceutical Co Ltd ADR and Westpac Banking Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00B200.00B300.00B400.00B20222023202420252026
327.66B
28.03B
(CHGCY) Total Revenue
(WEBNF) Total Revenue
Values in USD except per share items

CHGCY vs. WEBNF - Profitability Comparison

The chart below illustrates the profitability comparison between Chugai Pharmaceutical Co Ltd ADR and Westpac Banking Corp over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
71.2%
39.3%
Portfolio components
CHGCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported a gross profit of 233.16B and revenue of 327.66B. Therefore, the gross margin over that period was 71.2%.

WEBNF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported a gross profit of 11.02B and revenue of 28.03B. Therefore, the gross margin over that period was 39.3%.

CHGCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported an operating income of 165.66B and revenue of 327.66B, resulting in an operating margin of 50.6%.

WEBNF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported an operating income of 4.92B and revenue of 28.03B, resulting in an operating margin of 17.6%.

CHGCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Chugai Pharmaceutical Co Ltd ADR reported a net income of 117.54B and revenue of 327.66B, resulting in a net margin of 35.9%.

WEBNF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Westpac Banking Corp reported a net income of 3.42B and revenue of 28.03B, resulting in a net margin of 12.2%.


Frequently Asked Questions


CHGCY and WEBNF have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WEBNF has higher volatility (11.84%) compared to CHGCY (10.86%). In terms of maximum drawdown, CHGCY dropped -59.68% vs WEBNF's -66.96%.

WEBNF currently has the higher Sharpe Ratio (0.51 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CHGCY and WEBNF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer